References
- Youan BB. (2010). Chronopharmaceutical drug delivery systems: Hurdles, hype or hope? Adv Drug Deliv Rev, 62:898–903.
- Shastry BS. (2005). Genetic diversity and new therapeutic concepts. J Hum Genet, 50:321–328.
- Shastry BS. (2006). Pharmacogenetics and the concept of individualized medicine. Pharmacogenomics J, 6:16–21.
- René W. (2010). The importance of chronotherapeutics in the treatment of rheumatoid arthritis. European Musculoskeletal Review, 5:9–13.
- Cutolo M, Straub RH. (2008). Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. Autoimmun Rev, 7:223–228.
- Straub RH, Cutolo M. (2007). Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum, 56:399–408.
- Cutolo M, Seriolo B, Craviotto C, Pizzorni C, Sulli A. (2003). Circadian rhythms in RA. Ann Rheum Dis, 62:593–596.
- Sahoo BK, Uday C, Jayanti M, Tapan KP. (2010). Optimization and validation of modulated release formulation of ranitidine HCl by response surface methodology. J Biomed Sci and Res, 2:76–85.
- Prabakaran L, Vishalini M. (2010). Hydrophilic polymers matrix systems of nifedipine sustained release matrix tablets: Formulation optimization by Response Surface Method (Box–Behnken technique). Der Pharmacia Sinica, 1:147–165.
- USP NF 2009. The official compendia of standards volume 1, The United States Pharmacopoiea, thirty second revision and The National Formulary, twenty seventh edition. MD: The United States Pharmacopoeial convention, 226,227,262,263.
- Bussemer T, Peppas NA, Bodmeier R. (2003). Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur J Pharm Biopharm, 56:261–270.
- Shivakumar HN, Sarasija S, Desai BG. (2006). Design and evaluation of pH sensitive multiparticulate systems for chronotherapeutic delivery of diltiazem hydrochloride. Indian J Pharm Sci, 68:781–787.
- Qureshi J, Amir M, Ahuja A, Baboota S, Ali J. (2008). Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma. Indian J Pharm Sci, 70:351–356.
- Herbig SM, Cardinal JR. (1995). Asymmetric-membrane tablet coatings for osmotic drug delivery. J Controlled Rel, 35:127–136.
- Al-Zoubi NM, AlKhatib HS, Obeidat WM. (2011). Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release. Drug Dev Ind Pharm, 37:798–808.
- Panda RR, Tiwary AK. (2012). Hot melt granulation: a facile approach for monolithic osmotic release tablets. Drug Dev Ind Pharm, 38:447–461.